Indication

Sickle cell disease with crisis

Sickle cell disease with crisis refers to an acute, severe clinical exacerbation occurring in patients with sickle cell disease, an inherited red blood cell disorder caused by abnormal hemoglobin variants. Read more about Sickle cell disease with crisis

5 drugs 5 manufacturers

Advertisement

Drugs that treat it

Common Sickle cell disease with crisis therapies.

Showing 1–5 of 5 drugs

Filter & compare in the drug finder →Opens the drug finder with Sickle cell disease with crisis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Sickle cell disease with crisis.

Sickle cell disease with crisis refers to an acute, severe clinical exacerbation occurring in patients with sickle cell disease, an inherited red blood cell disorder caused by abnormal hemoglobin variants.

The condition primarily impacts the hematologic and vascular systems, affecting individuals possessing sickling hemoglobinopathies.

Pathophysiologically, deoxygenated sickle hemoglobin polymerizes, deforming erythrocytes into rigid, sickle-shaped cells that occlude microvasculature and provoke tissue ischemia, inflammation, and downstream organ dysfunction.

Defining clinical presentations most commonly encompass acute vaso-occlusive pain episodes affecting the bones, chest, back, and extremities, as well as acute life-threatening emergencies such as acute chest syndrome, splenic sequestration, and aplastic crises.

Personalize your experience

Follow Sickle cell disease with crisis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it